Professional Documents
Culture Documents
Nicolás Alberto Cely Aldana Interno Fujnc Agosto-2020
Nicolás Alberto Cely Aldana Interno Fujnc Agosto-2020
Interno
FUJNC
Agosto-2020
Definición
Disfunción Shunt
cerebral : portosistemico
Hepática Alteraciones
subclínicas al
coma
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the European Association
for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol
(2014), http://dx.doi.org/10.1016/j.jhep.2014.05.042
Epidemiología
Encefalopatía Encefalopatía
manifiesta:30%-40%- encubierta:20% -80%
cirrosis. en cirrosis.
-Recurrentes Rx 40%-
-Primer episodio Rx 6 meses, a pesar del -TIPS es 10%-50% 1
40% en 1 año. tratamiento con año.
lactulosa.
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the European Association
for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol
(2014), http://dx.doi.org/10.1016/j.jhep.2014.05.042
66% en el riesgo de mortalidad en
lista de espera de 90 días
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the European Association
for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol
(2014), http://dx.doi.org/10.1016/j.jhep.2014.05.042
Montagnese, S., Russo, F. P., Amodio, P., Burra, P., Gasbarrini, A., Loguercio, C., … Scarpignato, C. (2018). Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the
Study of the Liver (AISF). Digestive and Liver Disease. doi:10.1016/j.dld.2018.11.035
Guía urgencias ministerio, tomo ii
Butterworth, RF (2019). Encefalopatía hepática en cirrosis:
patología y fisiopatología. Drogas. doi: 10.1007 / s40265-018-
1017-0
Nutrition in Clinical Practice,Volume 0 Number 0, 2019 1–13, 2019 American Society
for,Parenteral and Enteral Nutrition, DOI: 10.1002/ncp.10458
Nutrition in Clinical Practice,Volume 0 Number 0, 2019 1–13, 2019 American Society
for,Parenteral and Enteral Nutrition, DOI: 10.1002/ncp.10458
Nutrition in Clinical Practice,Volume 0 Number 0, 2019 1–13, 2019 American Society
for,Parenteral and Enteral Nutrition, DOI: 10.1002/ncp.10458
N Engl J Med 2016; 375: 1660-1670
DOI: 10.1056 / NEJMra1600561
Nature Reviews Neuroscience volume 14, pages851–858(2013)
Montagnese, S., Russo, F. P., Amodio, P., Burra, P., Gasbarrini, A., Loguercio, C., … Scarpignato, C. (2018). Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the
Study of the Liver (AISF). Digestive and Liver Disease. doi:10.1016/j.dld.2018.11.035
Falla hepática Aguda
Aminotransferasas elevadas
(a menudo con niveles Tiempo de protrombina
Encefalopatía hepática
anormales de bilirrubina y prolongado (INR ≥1,5)
fosfatasa alcalina)
Clínicamente
indetectable
Test psicométricos y
Dx: 2 pruebas (PHES)
neurofisiológicos
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the European Association
for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol
(2014), http://dx.doi.org/10.1016/j.jhep.2014.05.042
Clínica-Encefalopatía Hepática encubierta
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the European Association
for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol
(2014), http://dx.doi.org/10.1016/j.jhep.2014.05.042
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the European Association
for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol
(2014), http://dx.doi.org/10.1016/j.jhep.2014.05.042
TEST NEUROPSICOLOGICOS
• See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/327756
TEST NEUROPSICOLOGICOS
TEST NEUROPSICOLOGICOS
EEG
-Método diagnóstico
más objetivo para la
detección de la EH.
- -Gasometría
Hemograma -Creatinina -Ionograma arterial
Ninguna prueba de
laboratorio por sí sola
hace el diagnóstico de
EH
TAC
EDEMA
HERNIAS
OTRAS
ALTERACIONES
Manganeso
Núcleos
Basales
Falla hepática
Util aguda mayor Nivel no se
evaluación Se sospecha 150 mg/dl relaciona
FP:40,%-FN:
inicial estado enfermedad alta nivel
49,2%
mental hepática posibilidad severidad
alterado edema clinica,
cerebral
90% controla
tratando factor
desencadénate
EA:
-Deshidratación(injuria renal)
-Broncoaspiración
-Trastorno electrolítico(hiponatremia)
-Irritación perineal
-Puede desencadena EH
Luo, M., Li, L., Lu, C.-Z., & Cao, W.-K. (2011). Clinical efficacy and safety of lactulose for minimal hepatic
encephalopathy. European Journal of Gastroenterology & Hepatology, 23(12), 1250–
1257. doi:10.1097/meg.0b013e32834d1938
:
RIFAXIMINA
Aumenta
actividad
glutamina
sintetasa